Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer

Fig. 4

Viability of Ishikawa, HEC1B, and HEC265 cells exposed to 500 ng/mL PRL for various durations. Cell proliferation at 72 h after prolactin (PRL) treatment a. Effect of metformin on PRL-induced cell proliferation at 72 h b. Columns, error bars represent the mean ± standard deviation of the mean. (*P < 0.01, **P < 0.05)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us